Hospitals and insurers have made clear their opposition to the Centers for Medicare and Medicaid Services proposed rule requiring the disclosure of their privately negotiated contract rates.
CMS is proposing that hospitals make public their payer-specific negotiated charges for a limited set of "shoppable" services or face civil monetary penalties, in a rule to go into effect on January 1, 2020. Comments were due by September 27.
Under the rule, hospitals would display payer-specific negotiated charges for at least 300 shoppable services, including 70 selected by CMS and 230 by the provider.
The American Hospital Association called it the wrong approach, even though it said it supported ensuring patients have the information they need, including knowing what their expected out-of-pocket costs would be. However, the AHA said, "Instead of helping patients estimate their out-of-pocket obligations, it would introduce confusion and fuel anticompetitive behavior among commercial health insurers in an already highly-concentrated insurance industry, seriously limiting the choices available to patients."
America's Essential Hospitals said, "We are particularly concerned that the agency's proposals regarding the public posting of charges, in particular the posting of negotiated rates, offer little benefit to the consumer, add substantial burden to hospitals, and pose harm to competition, potentially driving up prices."
America's Health Insurance plans said that forcing disclosure of privately and competitively negotiated rates will not provide consumers with information that is actionable or helpful. I
"Instead,"AHIP said, "it will hamper competitive negotiations and push healthcare prices and premiums higher for patients, consumers, businesses and taxpayers. This proposed rule also has significant implications for, and is interconnected with, other proposed rules regarding interoperability of health care data. We are concerned that unknown entities will have open access to the data, with few restrictions on how they may use it."
WHY THIS MATTERS
CMS released the proposals on July 29 in the 2020 hospital outpatient prospective payment and ambulatory surgical center payment rule.
The rule also has three additional proposed policies that run afoul of the law, the AHA said.
Specifically, the AHA opposes completion of the phase-in of payment reductions for the hospital outpatient clinic visit in excepted off-campus provider-based departments to the "physician fee schedule equivalent" rate of 40% of the outpatient prospective payment system rate.
The AHA said the proposal "exceeds the Administration's legal authority and should be abandoned."
The AHA has already won a case in court on the government's site neutral payment policy.
"On the clinic visit policy, we remind CMS that the agency was recently found by the courts to have exceeded its statutory authority when it cut the payment rate for clinic services at excepted off-campus provider-based departments," the AHA said.
Hospitals also object to continuing the current policy that pays for separately payable drugs acquired through the 340B drug savings program at the rate of average sales price minus 22.5%.
And the AHA objects to the implementation of a prior authorization process for five categories of outpatient department services.
THE LARGER TREND
On September 17, a federal judge ruled in favor of the AHA and hospital organizations, saying CMS exceeded its statutory authority when it reduced payments for hospital outpatient services provided in off-campus provider-based departments that were grandfathered under the Bipartisan Budget Act of 2015.
The AHA, joined by the Association of American Medical Colleges and several member hospitals, had filed the lawsuit in December.
ON THE RECORD
America's Essential Hospitals said, "These cuts deter hospitals from expanding access in communities with the most need for healthcare services and run counter to CMS' goal of integrated, coordinated healthcare.
"Taken together, these proposals would have a chilling effect on beneficiary access to care while also increasing regulatory burden," the AHA said.
Email the writer: email@example.com